相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Incorporation of multicellular spheroids into 3-D polymeric scaffolds provides an improved tumor model for screening anticancer drugs
Won Jin Ho et al.
CANCER SCIENCE (2010)
Quantitative Metabolome Profiling of Colon and Stomach Cancer Microenvironment by Capillary Electrophoresis Time-of-Flight Mass Spectrometry
Akiyoshi Hirayama et al.
CANCER RESEARCH (2009)
Gemcitabine sensitization by checkpoint kinase 1 inhibition correlates with inhibition of a Rad51 DNA damage response in pancreatic cancer cells
Leslie A. Parsels et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Matthew G. Vander Heiden et al.
SCIENCE (2009)
Why does cytotoxic chemotherapy cure only some cancers?
Philip Savage et al.
NATURE CLINICAL PRACTICE ONCOLOGY (2009)
Chronic hypoxia decreases synthesis of homologous recombination proteins to offset chemoresistance and radioresistance
Norman Chan et al.
CANCER RESEARCH (2008)
ATM and the Mre11-Rad50-Nbs1 complex respond to nucleoside analogue-induced stalled replication forks and contribute to drug resistance
Brett Ewald et al.
CANCER RESEARCH (2008)
Cellular life span and the Warburg effect
Hiroshi Kondoh
EXPERIMENTAL CELL RESEARCH (2008)
Nucleoside analogs: molecular mechanisms signaling cell death
B. Ewald et al.
ONCOGENE (2008)
HYPOXIA AND METABOLISM SERIES - TIMELINE The impact of O2 availability on human cancer
Jessica A. Bertout et al.
NATURE REVIEWS CANCER (2008)
Hypoxia, DNA repair and genetic instability
Robert G. Bristow et al.
NATURE REVIEWS CANCER (2008)
Dissociation of gemcitabine sensitivity and protein kinase B signaling in pancreatic ductal adenocarcinoma models
Nhu-An Pham et al.
PANCREAS (2007)
Dual inhibition of PI3K/Akt signaling and the DNA damage checkpoint in p53-deficient cells with strong survival signaling - Implications for cancer therapy
Andrzej Skladanowski et al.
CELL CYCLE (2007)
The Warburg effect and its cancer therapeutic implications
Zhao Chen et al.
JOURNAL OF BIOENERGETICS AND BIOMEMBRANES (2007)
H2AX phosphorylation marks gemcitabine-induced stalled replication forks and their collapse upon S-phase checkpoint abrogation
Brett Ewald et al.
MOLECULAR CANCER THERAPEUTICS (2007)
Targeting checkpoint kinase 1 in cancer therapeutics
Archie N. Tse et al.
CLINICAL CANCER RESEARCH (2007)
Pharmacological abrogation of S-phase checkpoint enhances the anti-tumor activity of gemcitabine in vivo
David J. Matthews et al.
CELL CYCLE (2007)
The relationship of premature mitosis to cytotoxicity in response to checkpoint abrogation and antimetabolite treatment
Meredith A. Morgan et al.
CELL CYCLE (2006)
Drug penetration in solid tumours
Andrew I. Minchinton et al.
NATURE REVIEWS CANCER (2006)
Identification of arctigenin as an antitumor agent having the ability to eliminate the tolerance of cancer cells to nutrient starvation
S Awale et al.
CANCER RESEARCH (2006)
Turning the replication checkpoint on and off
YW Zhang et al.
CELL CYCLE (2006)
Akt-mediated valosin-containing protein 97 phosphorylation regulates its association with ubiquitinated proteins
JB Klein et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Role of checkpoint kinase 1 in preventing premature mitosis in response to gemcitabine
MA Morgan et al.
CANCER RESEARCH (2005)
Hypoxia increases resistance of human pancreatic cancer cells to apoptosis induced by gemcitabine
K Yokoi et al.
CLINICAL CANCER RESEARCH (2004)
Kigamicin D, a novel anticancer agent based on a new anti-austerity strategy targeting cancer cells' tolerance to nutrient starvation
J Lu et al.
CANCER SCIENCE (2004)
Why do cancers have high aerobic glycolysis?
RA Gatenby et al.
NATURE REVIEWS CANCER (2004)
Proteomic analysis of the TGF-β signaling pathway in pancreatic carcinoma cells using stable RNA interference to silence Smad4 expression
T Imamura et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
UCN-01-induced cell cycle arrest requires the transcriptional induction of p21waf1/cip1 by activation of mitogen-activated protein/extracellular signal-regulated kinase kinase/extracellular signal-regulated kinase pathway
MM Facchinetti et al.
CANCER RESEARCH (2004)
Mechanisms of apoptosis induction by nucleoside analogs
D Sampath et al.
ONCOGENE (2003)
Molecular regulation of vessel maturation
RK Jain
NATURE MEDICINE (2003)
Molecular targeting therapy of cancer: drug resistance, apoptosis and survival signal
T Tsuruo et al.
CANCER SCIENCE (2003)
MRI of the tumor microenvironment
RJ Gillies et al.
JOURNAL OF MAGNETIC RESONANCE IMAGING (2002)
Hypoxia and nitric oxide treatment confer tolerance to glucose starvation in a 5′-AMP-activated protein kinase-dependent manner
H Esumi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Inhibition of cyclin-dependent kinase 2 by the Chk1-Cdc25A pathway during the S-phase checkpoint activated by fludarabine: Dysregulation by 7-hydroxystaurosporine
D Sampath et al.
MOLECULAR PHARMACOLOGY (2002)
Hypoxia-inducible factor (HIF1A and HIF2A), angiogenesis, and chemoradiotherapy outcome of squamous cell head-and-neck cancer
MI Koukourakis et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2002)
Hypoxia - A key regulatory factor in tumour growth
AL Harris
NATURE REVIEWS CANCER (2002)
HIF-1, O2, and the 3 PHDs:: How animal cells signal hypoxia to the nucleus
GL Semenza
CELL (2001)
Tumor hypoxia:: Definitions and current clinical, biologic, and molecular aspects
M Höckel et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2001)
UCN-01 enhances the in vitro toxicity of clinical agents in human tumor cell lines
A Monks et al.
INVESTIGATIONAL NEW DRUGS (2000)
分享论文
